skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Navigating the issues presented by biosimilars is becoming more complicated. With new barriers facing biosimilar originator companies and threatening to derail development, knowing how to formulate and manage your own biosimilar action plan is critically important.

Explore the components essential for understanding how biosimilar originator companies are responding to threats to their profit margins with this webinar recording from Informa Pharma Intelligence.

Experts from Scrip, part of the Informa Pharma Intelligence suite of tools, used data from across Pharma Intelligence to present vital information about the issues facing the biosimilars market and what they might mean for the future.

Listen to the recording now, where Scrip experts will be:

  • Analyzing the exposure of key originator companies to biosimilar competition
  • Considering the different tactics that originators are using in the face of biosimilar competition
  • Examining the situation across global markets, including the regulatory environments
  • Reviewing the first Humira biosimilars to launch in Europe
  • Exploring how the first US biosimilars are trending and the challenging commercial dynamics
  • Providing insights into likely future developments and trends

    The slides are available to download here

    Read also

    • Scrip: industry news and insights, Medtech Insight: global m...

      Pharmaceutical News and Insights

      Understand what’s happening in the market right now and what it means for the future of your business with news and insight from our team of journalists and analysts.  Pharma Intelligence's News Sources are essential for anyone making commercial decisions in the pharmaceutical industry.

    • In Vivo: strategic insights for life sciences decision-maker...

      Pharma News and Healthcare Business Insights

      Pharma Intelligence offers a wealth of pharmaceutical industry news and strategic insight into the healthcare & biotechnology markets from around the world. Working in an interconnected global network, our 65 journalists and over 300 in-house analysts supply comprehensive analysis and reports.

    • Scrip: industry news and insights

      Idorsia’s Quviviq Needs To Rise And Shine After Slow Launch

      26 Jul 2022

      The company’s Quviviq launch has fallen short of early expectations, but Idorsia believes a patient approach will pay off for...


    Next steps

    Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

    Request live demo now:

    Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

    Contact us for product technical and account support.

    • US Toll-Free   : +1 888 670 8900 
    • US Toll             : +1 212-600-3520
    • UK & Europe : +44 (0) 208 052 0700

    Have an immediate and specific information need?

    Browse and buy from 1000s of analysis and research reports now: